Pharma News - Marketing/Media/ROI News & Articles

981 Study Results: Multiple Sclerosis Patients Have Significant and Sustained Reduction in Disability and Risk Of Relapse On Alemtuzumab Versus Approved Full Text Genzyme, October 24, 2008

982 Abraxis BioScience and Specialised Therapeutics Australia Announce Approval to Market ABRAXANE for Metastatic Breast Cancer in Australia Full Text Corporate News Releases - The Healthcare Sales & Marketing Network, October 23, 2008

983 Medtronic Submitted Pre-Market Approval Application For FDA Approval of InterStim Therapy for Fecal Inconti Full Text Corporate News Releases - The Healthcare Sales & Marketing Network, October 23, 2008

984 FDA Grants Permission For Export of Antigenics’ Oncophage to Russia Full Text Agenus, October 23, 2008

985 Earnings rise, but Lipitor sales slow for Pfizer Full Text Corporate News Releases - The Healthcare Sales & Marketing Network, October 23, 2008

986 Basilea's Toctino (alitretinoin) receives marketing authorization in France Full Text Corporate News Releases - The Healthcare Sales & Marketing Network, October 22, 2008

987 Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder Full Text Corporate News Releases - The Healthcare Sales & Marketing Network, October 22, 2008

988 GSK’s Emerging Markets strategy advances with acquisition in Egypt Full Text PharmiWeb, October 21, 2008

989 Cardiovascular safety of vildagliptin, sitagliptin and others in the new DPP-4 inhibitor class of antidiabetic agents Full Text PharmiWeb, October 20, 2008

990 TomoTherapy and Hitachi Medical Corporation Sign Letter of Intent for Distribution in Japan Full Text Corporate News Releases - The Healthcare Sales & Marketing Network, October 20, 2008

991 InterCure Continues Retail Momentum Through New Wholesale Distribution Full Text Corporate News Releases - The Healthcare Sales & Marketing Network, October 17, 2008

992 ROTATEQ Receives WHO Pre-qualification Full Text Merck, October 15, 2008

993 Baxa Ltd Launches ZR Pre-Filled Saline Flush Syringes Full Text Corporate News Releases - The Healthcare Sales & Marketing Network, October 15, 2008

994 Environmental Tectonics Corporation Announces a Multiple Sale of Hyperbaric Monoplace Chambers to Comprehensive Healthcare Solutions Full Text Corporate News Releases - The Healthcare Sales & Marketing Network, October 10, 2008

995 EpiCept Receives Ceplene(R) Marketing Approval in Europe Full Text Corporate News Releases - The Healthcare Sales & Marketing Network, October 10, 2008

996 IPSOGEN expands its U.S. presence through licensing agreement with Quest Diagnostics Full Text Corporate News Releases - The Healthcare Sales & Marketing Network, October 10, 2008

997 Osteoporosis & Bone Metabolism Disorders Market 2008-2023 Full Text PharmiWeb, October 10, 2008

998 Circassia Acquires North American and Japanese Rights to Dopexamine Full Text Corporate News Releases - The Healthcare Sales & Marketing Network, October 9, 2008

999 BioMarin and Summit plc Sign Worldwide Licensing Agreement Full Text PharmiWeb, October 9, 2008

1000 Cardima Appoints Japan Lifeline as Its Distribution Partner in Japan for PATHFINDER Diagnostic Line of Catheters Full Text Corporate News Releases - The Healthcare Sales & Marketing Network, October 9, 2008

1 Valeant Pharmaceuticals International, Inc. Agrees to Acquire Obagi Medical Products, Inc. for $19.75 Per Share in Cash Valeant Pharmaceuticals International, March 21, 2013    Free full text

2 Boston Scientific Schedule Of Major Presentations At The American College Of Cardiology 2013 Boston Scientific, March 5, 2013    Free full text

3 Pfizers BOSULIF (bosutinib) Receives Conditional Marketing Authorization From The European Commission Pfizer, March 29, 2013    Free full text

4 Navigating Emerging Markets - Latin America BioPharm International, April 18, 2013    Free full text

5 Pfizer's Palbociclib (PD-0332991) Receives Food And Drug Administration Breakthrough Therapy Designation For Potential Treatment Of Patients With Breast Cancer Pfizer, April 15, 2013    Free full text